Actavis Pharma Inc
General
Total Cases85
Active Cases--
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
L3
E
PTAB
L1
D
CAFC
L3
C
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
---|---|---|
02/07/24 | Letter to Randall C. Lohan, Clerk and Nicole Fasano, Case Manager from David A. Bilson regarding Defendant's trial exhibits in this matter may be destroyed. (Bilson, David) (Entered: 02/07/2024) | |
02/07/24 | Letter to Randall C. Lohan, Clerk and Nicole Fasano, Case Manager from David A. Bilson regarding Defendant's trial exhibits in this matter may be destroyed. (Bilson, David) (Entered: 02/07/2024) | |
02/07/24 | Letter to Randall C. Lohan, Clerk and Nicole Fasano, Case Manager from David A. Bilson regarding Defendant's trial exhibits in this matter may be destroyed. (Bilson, David) (Entered: 02/07/2024) | |
02/07/24 | Remark: Defendant Actavis Laboratories FL, Inc.'s trial exhibits have been destroyed per D.I. 216 . (nmf) (Entered: 02/07/2024) | |
02/07/24 | Remark: Defendant Actavis Laboratories FL, Inc.'s trial exhibits have been destroyed per D.I. 216 . (nmf) (Entered: 02/07/2024) | |
02/07/24 | Remark: Defendant Actavis Laboratories FL, Inc.'s trial exhibits have been destroyed per D.I. 216 . (nmf) (Entered: 02/07/2024) | |
02/06/24 | ACKNOWLEDGMENT OF RECEIPT of Plaintiff's Trial Exhibits (nmf) (Entered: 02/06/2024) | |
02/06/24 | ACKNOWLEDGMENT OF RECEIPT of Plaintiff's Trial Exhibits (nmf) (Entered: 02/06/2024) | |
02/06/24 | ACKNOWLEDGMENT OF RECEIPT of Plaintiff's Trial Exhibits (nmf) (Entered: 02/06/2024) | |
04/11/23 | ACKNOWLEDGMENT OF RECEIPT of Plaintiff's Trial Exhibits. Filed by Amgen Inc.. (vfm) (Entered: 04/11/2023) |